June 1, 2020

We launched Coviside​ with a simple goal to utilize our resources to help those who need it most. Our nation’s nurses have had their resilience tested for months now putting their lives on the line everyday. We want to express our utmost appreciation for all of their unbelievable work.

Coviside is a hand s...

May 23, 2020

C2I alumni, SQZ Biotechnologies, announced a $65M investment by Roche to push a cancer vaccine for HPV-positive tumors through phase 1 and expand their signature cell-squeezing technology beyond oncology into infectious diseases.

SQZ Biotechnologies signature cancer pipeline is based on a cell therapy plat...